Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery

Inclusion Criteria: * Cataract surgery candidate and glaucoma present in at least one eye. * Minimally-invasive glaucoma surgery candidate in that same eye. Defined by having ocular hypertension requiring a medication, OR as by having mild, moderate, or severe glaucoma that is sufficiently stable and appropriate for operation. Exclusion Criteria: * Maintains regular use (daily or more) of systemic or ocular steroids at time of enrollment * Maintains regular use (daily or more) of systemic or ocular nonsteroidal anti-inflammatory drugs at time of enrollment * Anterior chamber cells present at time of enrollment * Recent febrile illness that precludes or delays participation for 3 months * Pregnancy or lactation * Known allergy to dexamethasone * Known allergy to prednisolone * Treatment with another investigational drug within the last 20 years * Current recreational drug use * Preexisting ocular pathology likely to confound the visual acuity or comfort endpoints including but not limited to: severe corneal scarring, ocular surface disease, diabetic retinopathy, or macular edema * Corneal or retinal procedures (laser or incisional) during the study period and 6 months prior